![]() |
市場調查報告書
商品編碼
2044297
神經放鬆和個人護理市場預測至2034年—按產品類型、成分類型、應用、分銷管道、最終用戶和地區分類的全球分析Neurorelaxation Personal Care Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Application, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球神經放鬆和個人護理市場將達到 31 億美元,並在預測期內以 12.9% 的複合年成長率成長,到 2034 年達到 82 億美元。
神經放鬆個人護理是指一系列外用護膚品、護髮產品、沐浴產品、身體護理產品和穿戴式產品,其配方或設計主要旨在調節使用者的自主神經系統壓力反應,減少皮質醇引起的皮膚發炎反應,並透過多感官神經機制促進身心放鬆。這些產品融合了經證實可影響邊緣系統活動的芳香療法植物精油、據報道可調節下丘腦-垂體-腎上腺軸(HPA軸)的護膚(如睡茄和聖羅勒)、CBD和源自大麻的化合物、富含鎂的沐浴添加劑,以及利用雙耳音頻刺激在個人護理過程中誘導副交感神經系統激活的神經聲學穿戴式設備。
全球心理健康危機和壓力相關的皮膚病
全球心理健康危機,表現為後疫情時代勞動力群體中壓力、焦慮和職業倦怠的急劇增加,正對皮膚產生直接影響,包括壓力誘發的痤瘡、濕疹加重、酒渣鼻惡化、酒糟加重以及皮質醇介導的炎症通路導致的皮膚過早老化。消費者越來越意識到心理壓力與皮膚可見劣化之間的心理皮膚學聯繫,因此增加了對能夠同時解決壓力管理、神經系統調節和局部皮膚健康問題的個人保健產品的投入。皮膚科醫師日益建議減輕壓力是控制發炎性皮膚病的關鍵,這進一步強化了以神經放鬆為目標的個人護理產品的臨床意義。
神經美容療法的相關說法缺乏科學證據。
由於神經美容科學是一個新興領域,品牌若想在涉及心理皮膚病學這一跨學科領域的個人保健產品中宣稱其具有特定的神經功效,將面臨監管和商業方面的挑戰。目前,關於特定局部成分如何透過非侵入性途徑與可測量的中樞神經系統放鬆聯繫起來的機制,證據仍然有限,這使得針對局部產品中有關大腦和身體壓力調節的宣傳可能面臨監管機構的糾正措施。面對成熟消費者對高階神經放鬆產品定價的質疑——他們要求提供同行評審的臨床證據——需要進行大量的研究。
男性舒緩壓力個人護理市場擴張
隨著壓力管理和心理健康日益成為男性消費者關注的重點,快速成長的男士個人護理市場為神經放鬆個人護理品牌的發展提供了巨大的未開發機會。承受職業壓力和倦怠的男性消費者構成了一個高階消費群體,他們更願意投資那些定位為提升工作效率和增強壓力應對能力的工具,而非傳統的美容產品。中性或男性專屬的神經放鬆個人保健產品,例如運動後恢復膏、舒緩壓力的剃須產品以及辦公桌舒緩噴霧,可以有效觸達這個龐大且持續成長的男性健康消費市場。
與專門用於心理健康的技術競爭
來自冥想應用、神經反饋設備、專業治療平台和藥物壓力管理方案等心理健康技術的競爭,給神經放鬆個人保健產品帶來了新的壓力。有較高壓力管理需求的消費者可能更傾向於選擇經過臨床檢驗的藥物和數位治療性介入,而不是那些聲稱具有神經療效但缺乏明確證據支持的個人保健產品。這個龐大的神經放鬆市場競爭激烈,主要來自擁有強大臨床證據支持能力的成熟製藥公司、保健品公司和數位健康公司。
疫情引發了全球前所未有的壓力和焦慮激增,從根本上改變了個人保健產品的購買行為,不再局限於傳統的整裝儀容功能,而是轉向能夠提供舒緩和減壓感官體驗的產品。在封鎖期間,人們將浴室和沐浴儀式作為主要的自我護理和壓力管理策略,這促使消費者持續增加對高階、具有神經放鬆功效的沐浴、身體保養和護膚產品的投入。疫情後,人們對神經放鬆類個人保健產品產品的強勁需求依然維持,這得益於既有的壓力管理和個人護理習慣,以及心理健康和自我護理產品購買量的結構性成長。
在預測期內,神經科技穿戴產品細分市場預計將佔據最大的市場佔有率。
在預測期內,神經穿戴裝置預計將佔據最大的市場佔有率。這主要歸功於神經放鬆類穿戴式神經刺激和生物感測設備的高階產品價值,以及消費者的高度參與。將即時壓力生物標記監測與主動神經調節干預(例如振動觸覺刺激、雙耳音頻和經皮神經刺激)相結合的設備,滿足了消費者對可量化壓力緩解效果的需求,而這種效果是外用個人保健產品無法實現的。因此,這些設備可以採用更高的定價和訂閱收入模式。
在預測期內,植物萃取物細分市場預計將呈現最高的複合年成長率。
在預測期內,植物萃取物細分市場預計將呈現最高的偏好,這主要得益於消費者對植物來源的神經放鬆活性成分(而非合成抗焦慮藥物)日益成長的偏好,以及越來越多的科學文獻支持某些植物化合物透過經皮吸收和嗅覺通路刺激發揮神經活性。薰衣草、檸檬香蜂草、西番蓮和纈草等植物萃取物已被證實具有GABA調節作用,因此吸引了眾多高階個人護理品牌的大量投資,用於配方研發,以彰顯經臨床驗證的神經放鬆成分的功效。
在預測期內,北美預計將保持最大的市場佔有率。這主要歸功於消費者對身心健康之間聯繫的高度重視、對壓力管理消費品的大力投資,以及先進的高階個人護理零售基礎設施,這些都為神經放鬆產品類型的發展提供了有力支撐。美國市場受惠於強大的健康文化、具有影響力的健康媒體平台(這些平台提升了人們對神經美容類別的認知度),以及對舒緩壓力個人護理品牌的巨額風險投資。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要是由於日本、韓國、中國和東南亞國家普遍存在嚴重的職場壓力,以及當地根深蒂固的傳統植物放鬆療法文化,使得消費者對植物來源減壓方式較為熟悉。韓妝和日妝產業的創新正在積極研發以傳統植物放鬆療法為基礎的神經放鬆護膚和個人護理產品,引領全球美容保養品產業的潮流。
According to Stratistics MRC, the Global Neurorelaxation Personal Care Market is accounted for $3.1 billion in 2026 and is expected to reach $8.2 billion by 2034 growing at a CAGR of 12.9% during the forecast period. Neurorelaxation personal care refers to a convergent category of topical skincare, haircare, bath, body, and wearable products formulated or engineered with the primary intent of modulating the user's autonomic nervous system stress response, reducing cortisol-mediated inflammatory skin reactions, and promoting psychodermatological relaxation through multisensory neurological mechanisms. These products incorporate aromatherapeutic botanical essential oils proven to influence limbic system activity, adaptogens including ashwagandha and holy basil with documented HPA axis modulation, CBD and hemp-derived compounds, magnesium-enriched bath formulations, and neuroacoustic wearable devices using binaural audio stimulation to induce parasympathetic nervous system activation during personal care rituals.
Global mental health crisis and stress-related skin conditions
The global mental health crisis, manifesting in dramatically elevated stress, anxiety, and burnout prevalence across post-pandemic working populations, is creating direct dermatological consequences, including stress-induced acne, eczema flares, rosacea exacerbations, psoriasis worsening, and premature aging driven by cortisol-mediated inflammatory pathways. Consumer recognition of the psychodermatological connection between psychological stress and visible skin deterioration is compelling investment in personal care products that simultaneously address stress, nervous system modulation and topical skin health. Dermatologists increasingly recommending stress reduction as integral to managing inflammatory skin conditions, elevates the clinical rationale for neurorelaxation personal care.
Scientific substantiation gaps for neurocosmetic claims
The emerging nature of neurocosmetic science creates regulatory and commercial challenges for brands seeking to make specific neurological efficacy claims for personal care products that touch the psychodermatological boundary. The mechanistic evidence connecting specific topical ingredient applications to measurable central nervous system relaxation outcomes through non-invasive delivery routes remains limited, creating vulnerability to regulatory enforcement actions challenging brain-body stress modulation claims for topical products. Consumer skepticism from sophisticated purchasers demanding peer-reviewed clinical substantiation for premium neurorelaxation pricing requires significant research investment.
Men's stress-relief personal care segment expansion
The rapidly growing men's personal care market, where stress management and mental wellness are increasingly accepted male consumer priorities, represents a largely underserved opportunity for neurorelaxation personal care brand development. Male consumers experiencing occupational stress and burnout represent a premium segment with a high willingness to invest in products positioned as performance recovery and stress resilience tools rather than traditional beauty products. Gender-neutral and masculine-positioned neurorelaxation personal care formats, including post-workout recovery balms, stress-relief shaving formulations, and office desk relaxation mists, can access the substantial and growing male wellness consumer market.
Competition from dedicated mental wellness technology
Consumer budget competition from dedicated mental wellness technology, including meditation apps, neurofeedback devices, professional therapy platforms, and pharmaceutical stress management solutions, creates substitution pressure for neurorelaxation personal care products. Consumers with significant stress management needs may prioritize clinically validated pharmaceutical or digital therapeutic interventions over personal care products whose neurological efficacy claims are less clearly substantiated. The large addressable neurorelaxation market is attracting competition from established pharmaceutical, supplement, and digital health companies with superior clinical evidence generation capabilities.
The pandemic created an unprecedented global stress and anxiety surge that fundamentally reshaped personal care purchasing toward products delivering calming, stress-relieving sensory experiences alongside conventional grooming functions. Bathroom and bath ritual elevation as a primary self-care stress management strategy during lockdowns permanently elevated consumer investment in premium neurorelaxation bath, body, and skincare products. Post-pandemic, entrenched stress management, personal care routines, and structural elevation of mental wellness self-care purchasing have sustained strong demand for neurorelaxation personal care products.
The neurocalming wearables segment is expected to be the largest during the forecast period
The neurocalming wearables segment is expected to account for the largest market share during the forecast period, due to the premium product value and strong consumer engagement that wearable neurostimulation and biosensing devices command within the neurorelaxation category. Devices combining real-time stress biomarker monitoring with active neuromodulation interventions, including vibrotactile stimulation, binaural audio, and transcutaneous vagus nerve stimulation, address consumer demand for measurable stress relief outcomes that topical personal care products cannot quantify, supporting substantially higher price points and device subscription revenue models.
The botanical extracts segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the botanical extracts segment is predicted to witness the highest growth rate, driven by expanding consumer preference for plant-derived neurorelaxation actives over synthetic anxiolytic ingredients, combined with growing scientific literature validating specific botanical compounds' neurological activity through dermal absorption and olfactory pathway stimulation. Lavender, lemon balm, passionflower, and valerian botanical extracts with documented GABA modulation activity are attracting significant formulation innovation investment from premium personal care brands seeking clinically defensible neurorelaxation ingredient claims.
During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness of the mind-body wellness connection, strong investment in stress management consumer products, and advanced prestige personal care retail infrastructure supporting neurorelaxation product category development. The United States market benefits from strong wellness culture, influential wellness media platforms driving neurocosmetic category education, and substantial venture investment in stress-relief personal care brand development.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to acute workplace stress prevalence across Japan, South Korea, China, and Southeast Asian economies combined with established traditional botanical relaxation remedy cultures providing consumer familiarity with plant-based stress relief. K-beauty and J-beauty industry innovation is actively developing neurorelaxation skincare and personal care formulations informed by traditional botanical relaxation medicine that are driving global category trend-setting.
Key players in the market
Some of the key players in Neurorelaxation Personal Care Market include L'Oreal S.A., Unilever PLC, Procter & Gamble Co., Estee Lauder Companies Inc., Johnson & Johnson, Beiersdorf AG, Colgate-Palmolive Company, Shiseido Company Limited, Kao Corporation, Coty Inc., Amway Corporation, Herbalife Nutrition Ltd., Natura & Co, The Body Shop International, Reckitt Benckiser Group, GSK plc, and Bayer AG.
In April 2026, L'Oreal S.A. launched a neurocosmetic face serum range incorporating clinically tested botanical cortisol-modulating extracts and psychodermatologically validated stress-barrier repair actives.
In March 2026, Shiseido Company Limited introduced a neurosensory bath ritual collection featuring Ayurvedic adaptogen infusions with clinical documentation of cortisol reduction and skin inflammation modulation.
In January 2026, Beiersdorf AG introduced a stress-relief body care range featuring a validated magnesium complex and a lavender neuroactive formulation, which demonstrated an autonomic nervous system relaxation response in consumer trials.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.